Epigenetic Mechanism of FMR1 Inactivation in Fragile X Syndrome
Overview
Reproductive Medicine
Authors
Affiliations
Fragile X syndrome is the most frequent cause of inherited intellectual disability. The primary molecular defect in this disease is the expansion of a CGG repeat in the 5' region of the fragile X mental retardation1 (FMR1) gene, leading to de novo methylation of the promoter and inactivation of this otherwise normal gene, but little is known about how these epigenetic changes occur during development. In order to gain insight into the nature of this process, we have used cell fusion technology to recapitulate the events that occur during early embryogenesis. These experiments suggest that the naturally occurring Fragile XFMR1 5' region undergoes inactivation post implantation in a Dicer/Ago-dependent targeted process which involves local SUV39H-mediated tri-methylation of histone H3K9. It thus appears that Fragile X syndrome may come about through inadvertent siRNA-mediated heterochromatinization.
Epigenetic insights into Fragile X Syndrome.
Xie L, Li H, Xiao M, Chen N, Zang X, Liu Y Front Cell Dev Biol. 2024; 12:1432444.
PMID: 39220684 PMC: 11362040. DOI: 10.3389/fcell.2024.1432444.
Edwards N, Combrinck C, McCaughey-Chapman A, Connor B Front Cell Neurosci. 2023; 17:1254412.
PMID: 37810261 PMC: 10552551. DOI: 10.3389/fncel.2023.1254412.
DIncal C, Broos J, Torfs T, Kooy R, Vanden Berghe W Cells. 2022; 11(8).
PMID: 35456004 PMC: 9029738. DOI: 10.3390/cells11081325.
Zhao X, Usdin K Int J Mol Sci. 2021; 22(17).
PMID: 34502075 PMC: 8431139. DOI: 10.3390/ijms22179167.
DNA Methylation, Mechanisms of Inactivation and Therapeutic Perspectives for Fragile X Syndrome.
Nobile V, Pucci C, Chiurazzi P, Neri G, Tabolacci E Biomolecules. 2021; 11(2).
PMID: 33669384 PMC: 7920310. DOI: 10.3390/biom11020296.